Shell Plc ADR (SHEL) concluded trading on Wednesday at a closing price of $67.38, with 5.08 million shares of worth about $342.21 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -0.07% during that period and on March 12, 2025 the price saw a gain of about 0.85%. Currently the company’s common shares owned by public are about 3.06B shares, out of which, 3.02B shares are available for trading.
Stock saw a price change of 1.94% in past 5 days and over the past one month there was a price change of 1.89%. Year-to-date (YTD), SHEL shares are showing a performance of 7.55% which increased to 4.76% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $60.15 but also hit the highest price of $74.61 during that period. The average intraday trading volume for Shell Plc ADR shares is 4.17 million. The stock is currently trading 0.55% above its 20-day simple moving average (SMA20), while that difference is up 2.08% for SMA50 and it goes to -0.96% lower than SMA200.
Shell Plc ADR (NYSE: SHEL) currently have 3.06B outstanding shares and institutions hold larger chunk of about 12.61% of that.
The stock has a current market capitalization of $203.25B and its 3Y-monthly beta is at 0.30. PE ratio of stock for trailing 12 months is 13.44, while it has posted earnings per share of $5.01 in the same period. Its PEG reads 2.73 and has Quick Ratio of 1.10 while making debt-to-equity ratio of 0.43. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SHEL, volatility over the week remained 1.62% while standing at 1.62% over the month.
Stock’s fiscal year EPS is expected to drop by -1.25% while it is estimated to increase by 7.08% in next year. EPS is likely to shrink at an annualized rate of 4.93% for next 5-years, compared to annual growth of 5.38% made by the stock over the past 5-years.
Coverage by Morgan Stanley stated Shell Plc ADR (SHEL) stock as an Overweight in their note to investors on January 07, 2025, suggesting a price target of $79.80 for the stock. Stock get a Neutral rating from Exane BNP Paribas on December 13, 2023.
